Related Experiment Videos
Aggravation of rat nephrotoxic serum nephritis by anti-myeloperoxidase antibodies
K Kobayashi1, T Shibata, T Sugisaki
1Department of Nephrology, Showa University School of Medicine, Tokyo, Japan.
Abstract:
To investigate a possible role of anti-neutrophil cytoplasmic antibodies directed against myeloperoxidase (MPO-ANCA) in glomerulonephritis, we prepared anti-rat MPO antiserum by immunization of rat MPO into a rabbit. Then we administered anti-rat MPO antiserum (group 1) or normal rabbit serum (NRS) (group 2) into rats before injection of nephrotoxic serum (NTS), which induced nephrotoxic serum nephritis (NTN). Other groups of rats received either anti-rat MPO anti-serum (group 3) or NRS (group 4) before injection of NRS but not NTS. Rats in group 1 and group 2 were sacrificed at either 3 hours, 15 hours, or 14 days after NTS injection. Rats in group 3 and group 4 were sacrificed at 15 hours after the last NRS injection. By light microscopy, in rats with NTN sacrificed at 3 hours, counts of polymorphonuclear leukocytes (PMN) per glomerulus were 21.6 +/- 3.5 in group 1 and 8.4 +/- 1.7 in group 2 (P < 0.01). At 15 hours, massive glomerular fibrin deposits were observed in group 1 rats (fibrin score, 131 +/- 8), but not in group 2 rats (fibrin score, 27 +/- 21; P < 0.01). By direct immunofluorescence microscopy, rat MPO was found along glomerular capillary walls more intensely in group 1 rats than in group 2 rats. No pathological alterations were found in group 3 and group 4 rats. Further, renal elution studies revealed that eluted rabbit IgG contained anti-rat MPO antibodies in group 1 rats but not in group 3 rats. These results suggest that the anti-MPO antibodies are directly involved in the more severe glomerular lesions in group 1 rats via interactions with MPO itself or activation of PMN, which release various kinds of mediators including MPO.
Insights
Anti-neutrophil cytoplasmic antibodies against myeloperoxidase (MPO-ANCA) significantly worsen glomerulonephritis in rats. These antibodies contribute to severe glomerular lesions by interacting with MPO or activating neutrophils.
Area of Science:
- Nephrology
- Immunology
- Pathology
Background:
- Glomerulonephritis is a kidney disease affecting the glomeruli.
- Anti-neutrophil cytoplasmic antibodies (ANCA) are implicated in various autoimmune diseases.
- Myeloperoxidase (MPO) is a key enzyme in neutrophil function.
Purpose of the Study:
- To investigate the role of MPO-ANCA in the pathogenesis of glomerulonephritis.
- To determine if MPO-ANCA exacerbates kidney damage in nephrotoxic serum nephritis (NTN).
Main Methods:
- Rats were immunized to produce anti-rat MPO antiserum.
- Rats received either anti-MPO antiserum or normal rabbit serum (NRS) before induction of NTN.
- Kidney tissues were analyzed using light microscopy, immunofluorescence, and elution studies at various time points.
Main Results:
- Rats treated with anti-MPO antiserum showed significantly higher polymorphonuclear leukocyte (PMN) counts in glomeruli.
- Massive glomerular fibrin deposits were observed in rats with anti-MPO antibodies.
- Direct immunofluorescence confirmed increased MPO presence along glomerular capillary walls in the anti-MPO group.
- Elution studies confirmed the presence of anti-MPO antibodies in affected rat kidneys.
Conclusions:
- MPO-ANCA plays a direct role in exacerbating glomerular lesions in glomerulonephritis.
- Anti-MPO antibodies may cause severe kidney damage through MPO interactions or neutrophil activation.
- These findings highlight the pathogenic potential of MPO-ANCA in kidney disease.